Through using neutralizing antibody and siRNA approaches to suppress PDL1–PD1 axis, we have verified that ABs switch macrophages from a pro‐inflammatory state to an anti‐inflammatory state through PDL1–PD1 axis, providing therapeutic benefits in the treatment of ALI and inflammatory arthritis. This evidence concerns the gene CD274 and acute respiratory distress syndrome.